Welcome to AstraZeneca United States

Beginning its journey in 1953, AstraZeneca became one of the first pharmaceutical companies operating in the United States


Latest News from AstraZeneca US


Researching antibodies to target COVID-19

AstraZeneca is joining forces with government and academia with the aim of discovering novel coronavirus-neutralising antibodies. Harnessing internal expertise and via new collaborations, the aim is to identify monoclonal antibodies that have the potential to recognise, bind to and neutralise the SARS-CoV-2 virus, to decrease the impact of COVID-19.


Latest AZ&You Blog Articles